cyto-012

N/A

Report date: 2025/03/19 11:39:40

Base Information

Drug Namecyto-012
Drug Alias Namerecombinant BoNT derivatives (CytoDel)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionBotulinum toxin modulators
TargetsBotulinum toxin
Therapy Area/IndicationsMuscle HypertoniaCerebral Palsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytoDel Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytoDel Inc
Inactive CompaniesN/A
Active IndicationsMuscle HypertoniaCerebral Palsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A